<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Maternal and fetal risk is high during pregnancy for young women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We analyzed outcome after a planned pregnancy program for these patients </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Between 1982 and 1994, 58 pregnancy were planned in 34 women with systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Nine of them had renal and 5 central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement; <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> was present in 8; steroid therapy was given in 24, immunosuppressors in 2 and plasma exchange in 1 </plain></SENT>
<SENT sid="4" pm="."><plain>At diagnosis of pregnancy, <z:chebi fb="0" ids="8382">prednisone</z:chebi> was prescribed (at least 10 mg/d), associated with aspirin in <z:hpo ids='HP_0000001'>all</z:hpo> non-symptomatic patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> followed by <z:chebi fb="5" ids="28304">heparin</z:chebi> at pre partum </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> was used in case of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Women with anti-SSA or B antibodies and no past history of congenital <z:hpo ids='HP_0001678'>atrioventricular block</z:hpo> were not given any specific treatment </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: An <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> flare-up occurred in 27% of the cases including 6% in post partum </plain></SENT>
<SENT sid="8" pm="."><plain>The flare-up was mild in <z:hpo ids='HP_0000001'>all</z:hpo> cases and treatment had to be changed in half of the cases </plain></SENT>
<SENT sid="9" pm="."><plain>There were 9 early abortions, 1 induced abortion for <z:e sem="disease" ids="C1705254" disease_type="Disease or Syndrome" abbrv="">congenital malformation</z:e>, 2 fetal <z:hpo ids='HP_0011420'>deaths</z:hpo>, 28 <z:hpo ids='HP_0001622'>premature deliveries</z:hpo> and 18 term deliveries </plain></SENT>
<SENT sid="10" pm="."><plain>Cesarean section was indicated in 8 cases </plain></SENT>
<SENT sid="11" pm="."><plain>Severe <z:e sem="disease" ids="C0854706" disease_type="Disease or Syndrome" abbrv="">neonatal infection</z:e> occurred in 2 premature infants and 1 other was growth retarded </plain></SENT>
<SENT sid="12" pm="."><plain>Cutaneous <z:e sem="disease" ids="C0409979" disease_type="Disease or Syndrome" abbrv="">neonatal lupus</z:e> was observed in 2 infants </plain></SENT>
<SENT sid="13" pm="."><plain>No <z:hpo ids='HP_0001678'>atrioventricular blocks</z:hpo> occurred </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: Fetal <z:hpo ids='HP_0011420'>death</z:hpo> or very <z:hpo ids='HP_0001622'>premature birth</z:hpo> were more frequent in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>When pregnancy is planned in women with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, live birth rate reaches 96% after exclusion of early and therapeutic abortions </plain></SENT>
<SENT sid="16" pm="."><plain>This rate is close to the rate in the general population </plain></SENT>
<SENT sid="17" pm="."><plain>The high rate of <z:hpo ids='HP_0001622'>premature birth</z:hpo> is the main risk, but there were no maternal nor <z:hpo ids='HP_0003811'>neonatal deaths</z:hpo> </plain></SENT>
</text></document>